Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. - Wikidata - wikimedia - TriplyDB

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.

http://www.wikidata.org/entity/Q41038524

about

Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature Emerging molecular classifications and therapeutic implications for gastric cancer Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways Genomic alterations and molecular subtypes of gastric cancers in Asians Novel targets in the treatment of advanced gastric cancer: a perspective review Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives Molecular classification and prediction in gastric cancer Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine Comprehensive mutation profiling of mucinous gastric carcinoma.Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers Immunological battlefield in gastric cancer and role of immunotherapies The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond Translating genomic profiling to gastrointestinal cancer treatment.Gastric cancer - clinical and epidemiological aspects.Assessing the clinical utility of genomic expression data across human cancers.A unified model of the hierarchical and stochastic theories of gastric cancer.The Origins of Gastric Cancer From Gastric Stem Cells: Lessons From Mouse Models.Gastric Cancer in the Era of Precision Medicine.Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.Molecular classifications of gastric cancers: Novel insights and possible future applications.Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer.Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer.Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53-dependent manner.The significance of a nineteenth century definition in the era of genomics: linitis plastica.Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature.Clinical impact of tumour biology in the management of gastroesophageal cancer EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.Helicobacter pylori, Cancer, and the Gastric Microbiota.Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas.Micronutrients: A double-edged sword in microbial-induced gastric carcinogenesis.Seom guidelines for the treatment of gastric cancer 2015.Patient-derived cell models as preclinical tools for genome-directed targeted therapy.Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis.A long non-coding RNA signature to improve prognosis prediction of gastric cancer.Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer.

P2860

Q26741242-4A4D1E54-C8DC-43EF-A1AE-F92BCFF7CCDB Q26745525-FFFAB9D3-7027-48F1-BD40-B5D42C5B1678 Q26748123-B2B1A2BC-D756-4C49-A168-3D6B728823E2 Q26751062-2F71C7F6-E2F3-4BCA-91E9-34D483EFCEC1 Q26765208-30C8624C-F826-4CE9-B7B1-E82EA12147B3 Q26779725-DEBF35B0-14CA-4218-BA83-0362FD43ED1D Q26783806-10A3AF4E-706F-4AEC-A3E1-1E083034A902 Q26785700-8A11EC9D-72EB-4372-B1D4-9FDFB8262DEF Q26800355-9C99A819-880C-4020-B17A-0E58B0C34A84 Q27853392-3939ACAB-EA5E-4829-B41F-C49E9FD39202 Q28066550-27DC87AE-47C7-40F9-9B86-3DD2E478DCD4 Q28071836-F7ABB6AA-EBF4-49DB-823F-B3447938F4F5 Q28078788-1C8EA6BA-470D-4530-AD40-1AA8AEB1CDCA Q30239109-E4787795-43BA-431C-83D7-8D1282F45D8C Q30248452-91F6AB23-FE80-4FE6-8DC4-19CA98000D13 Q31109151-7E0119EF-8CF6-4B2F-9D46-E41441F9C5D8 Q33577624-C9E8A414-BCA6-49DC-99FC-8AFEB9410291 Q33600436-CC202CE2-1FD7-4BAE-9562-53F8DE1541E1 Q33600457-945AAFFD-4C52-4D25-8C0B-AF27C4378EE8 Q33657952-83F2202B-9D08-4BC9-AB24-B1201155AA4D Q33688662-9D9E180E-8B26-4C2F-875B-D1FEADC7D8A0 Q33696201-38ABF9A8-F44E-422F-906B-6B3679A0595D Q33709895-9976EFC7-1FE8-40F0-8638-D22D9EC6F82A Q33829437-5C730BA1-D2D4-408C-9D82-31568D77A0A7 Q33844651-8C84A948-49D4-4546-B54A-9879803E1F34 Q33876785-101C0420-DCD8-46DA-90D1-1D6105FDE6BD Q33888813-9E0DE6E1-8A39-4508-9F1A-937B3302D75A Q33895591-3006538C-CE4D-4FE5-928A-A930A23CC9E9 Q33922534-7644CF50-A4DD-4A5D-82A4-6DCB19410474 Q36069955-3BEBB475-19E8-449D-954E-20DF7FDCF040 Q36116464-72A3C7D2-DFBA-4034-89FC-059BDE12A1FB Q36234652-E8D82292-3092-46E1-AEDE-38794D56D669 Q36326147-2F6460CA-FB44-42D8-AE9D-FE11D5204E4B Q36400378-16D90716-712B-4D64-AD96-E159C20EA60C Q36413247-BEE131DC-381C-4253-8872-F43836F7DCCE Q36633405-593A9D55-7438-4462-BFA6-F9DC5ABBA883 Q36670779-69BFD7C8-14FD-4ED9-B661-41AD80157EB4 Q37268013-48FE2C5E-6B95-4B81-B262-7C4F7FBFC5DD Q37315416-E79F56B4-92EE-42CA-AAB5-C7B346276476 Q37330144-E48D322F-F16E-4379-850C-6406EF73A583

P2860

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.

http://www.wikidata.org/entity/Q41038524

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Molecular analysis of gastric ...... th distinct clinical outcomes.

@en

type

label

Molecular analysis of gastric ...... th distinct clinical outcomes.

@en

prefLabel

Molecular analysis of gastric ...... th distinct clinical outcomes.

@en

P1433

Q41038524-9035A7AA-D97F-41B8-B1B9-C4B06E342CB9

P1476

Q41038524-367B15E3-B5DB-4B72-810E-8A6C038EACE4

P2093

Q41038524-0A840746-5B6E-4461-8950-E94D4291259C

Q41038524-0C8FEB8A-0DF8-40F2-885F-B63B12BD380E

Q41038524-108960CC-FFA0-4CE2-B1EB-BE54CB7BF296

Q41038524-1B9A26FB-1172-4244-A7EB-5F7D5F4140B6

Q41038524-274AA9EC-3FE2-4DB8-9085-688B4AC2E6AD

Q41038524-2B1F7EA8-FD1F-4076-8E03-29CCEAFE4119

Q41038524-3B188C9D-25C1-47BF-9615-24FE61731325

Q41038524-3CD2ECEB-CD3B-4D6E-AADD-D47825C59AB6

Q41038524-40E31BDF-15D9-499E-A9A4-30FFF93F2FCC

Q41038524-488A0FD2-A629-4ABF-93C6-F139AADD5B89

P2860

Q41038524-046E8DA7-4EDF-443E-808E-8FFF8EF81CBC

Q41038524-12A0B4FA-A898-4A42-AB7A-9DD6EA2A9E65

Q41038524-2791E822-48EE-4C7E-9C5F-FF36481CD8D0

Q41038524-2C127A17-5AB2-48F0-ABDC-CB384E9C325A

Q41038524-306B8B02-AAC7-4F70-80DA-4737868FA928

Q41038524-31D28D92-FC46-4AEE-A649-A38B7A4CAA2E

Q41038524-348F010C-431E-445A-B00C-6CB9B1FDBC0F

Q41038524-3E194628-602F-4254-ADD1-9CC597F4F8DD

Q41038524-427E1CE6-B8C6-4CEA-9C8C-452B8787F055

Q41038524-4D39D667-FF6B-4793-8BCD-D94823C48970

P2888

Q41038524-91FEB36B-8224-4CB3-A4F7-6D334F655C28

P304

Q41038524-C1004E72-813E-4A0F-988C-74EC0EFF0B4C

P31

Q41038524-783D402F-979B-4DA6-832D-2C6E12BB0D4C

P356

Q41038524-D4A6AB88-0EAA-472E-BD42-0BD7F6E5405B

P407

Q41038524-70097FB6-FF1F-4E60-8B97-70892D42335A

P433

Q41038524-2A3040E1-F220-4440-91A0-CE0861432F39

P478

Q41038524-1DC03103-F305-47BF-9B35-33D2EBFF6661

P50

Q41038524-8C358325-5DC9-4100-85D8-E76F8DDFAF91

P577

Q41038524-0485185B-A2A4-4780-8EF6-70D8A35FB79B

P698

Q41038524-46020C42-E726-4A38-AA8E-6DBF1B5E1CE9

P356

P1433

Nature Medicine

P1476

Molecular analysis of gastric ...... ith distinct clinical outcomes

@en

P2093

Amit Aggarwal

http://www.w3.org/2001/XMLSchema#string

Andrey Loboda

http://www.w3.org/2001/XMLSchema#string

Christoph Reinhard

http://www.w3.org/2001/XMLSchema#string

Dai Hongyue

http://www.w3.org/2001/XMLSchema#string

In-Gu Do

http://www.w3.org/2001/XMLSchema#string

Insuk Sohn

http://www.w3.org/2001/XMLSchema#string

Jae Moon Bae

http://www.w3.org/2001/XMLSchema#string

Jake Fu

http://www.w3.org/2001/XMLSchema#string

James Hardwick

http://www.w3.org/2001/XMLSchema#string

Jason C Ting

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Comprehensive molecular characterization of human colon and rectal cancer

Comprehensive molecular portraits of human breast tumours

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Comprehensive molecular characterization of gastric adenocarcinoma

HER2 testing in gastric cancer: a practical approach

Integrated genomic characterization of endometrial carcinoma

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

P2888

P304

449-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.3850

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25894828

http://www.w3.org/2001/XMLSchema#string